Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Neuromolecular Medicine|March 28, 2014
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosisFrancesco Mori, Carolina G Nicoletti, Silvia Rossi, et al.
Molecular Pharmacology|April 29, 2010
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibitionSilvia Rossi, Valentina De Chiara, Alessandra Musella, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2010
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosisFrancesco Mori, Silvia Rossi, Giulia Sancesario, et al.
Brain, Behavior, and Immunity|April 9, 2011
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitisSilvia Rossi, Roberto Furlan, Valentina De Chiara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitisAntonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.
Pageof 4